Nektar (NKTR): Keep Strong Buy - REZPEG Launch Is a Clear Price-Action Catalyst
Nektar trades near $73.50 after a big run; the imminent commercial development of rezpegaldesleukin (REZPEG) and fresh institutional buying create asymmetric upside vs defined downside. This trade plan targets $95 over the next 45 trading days with a strict $64 stop to respect binary clinical and legal risks.